MRPL9
Large ribosomal subunit protein bL9m
Also known as: RM09_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYD2
- Gene
- MRPL9
- Ensembl
- ENSG00000143436
- Chromosome
- 1
- Canonical length
- 267 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This is a nuclear gene encoding a protein component of the 39S subunit of the mitochondrial ribosome. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
267 residues, UniProt reviewed canonical sequence.
>Q9BYD2|MRPL9
1 MAAPVVTAPG RALLRAGAGR LLRGGVQELL RPRHEGNAPD LACNFSLSQN RGTVIVERWW
61 KVPLAGEGRK PRLHRRHRVY KLVEDTKHRP KENLELILTQ SVENVGVRGD LVSVKKSLGR
121 NRLLPQGLAV YASPENKKLF EEEKLLRQEG KLEKIQTKAG EATVKFLKSC RLEVGMKNNV
181 KWELNPEIVA RHFFKNLGVV VAPHTLKLPE EPITRWGEYW CEVTVNGLDT VRVPMSVVNF
241 EKPKTKRYKY WLAQQAAKAM APTSPQILocalizationUniProt · AlphaFold · HPA
Whether an antibody against MRPL9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 67 nTPM
- tongue: 52 nTPM
- parathyroid gland: 46 nTPM
- thymus: 43 nTPM
- bone marrow: 39 nTPM
- kidney: 38 nTPM
Single-cell type
- extravillous trophoblasts: 144 nCPM
- migrating cytotrophoblasts: 129 nCPM
- esophageal basal cells: 126 nCPM
- cytotrophoblasts: 114 nCPM
- early spermatids: 111 nCPM
- esophageal suprabasal cells: 109 nCPM
Immune cell
- T-reg: 122 nTPM
- myeloid DC: 99 nTPM
- memory B-cell: 97 nTPM
- memory CD8 T-cell: 96 nTPM
- MAIT T-cell: 95 nTPM
- memory CD4 T-cell: 95 nTPM
Brain region
- cerebellum: 26 nTPM
- hypothalamus: 26 nTPM
- cerebral cortex: 24 nTPM
- white matter: 24 nTPM
- medulla oblongata: 24 nTPM
- spinal cord: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- -0.47
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 16% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Large ribosomal subunit protein bL9/RNase H1, N-terminal
- Large ribosomal subunit protein bL9
- Large ribosomal subunit protein bL9, N-terminal
- Large ribosomal subunit protein bL9, N-terminal domain superfamily
- Large ribosomal subunit protein bL9m, C-terminal domain
- Large ribosomal subunit protein bL9m, N-terminal domain
- Ribosomal protein L9, N-terminal domain
- Large ribosomal subunit protein bL9m C-terminal domain
- Large ribosomal subunit protein bL9m N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MRPL9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MRPL9 as an antibody target. Whether an autoantibody or antibody against MRPL9 could matter depends on whether native MRPL9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MRPL9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MRPL9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...